SCHEMBL6211554

SCHEMBL6211554

CC(CCNC(=O)OCc1ccccc1)CC(=O)N1CCC2C1C(=O)CN2C(=O)Cc1cccnc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 2/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TP53 P04637 1/20 0.39
GFER P55789 1/20 0.39
GAA P10253 1/20 0.38
CTSK P43235 3/20 0.38
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
EPHX2 P34913 1/20 0.37
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.37
MAPT P10636 1/20 0.37
FAAH O00519 1/20 0.37
PAX8 Q06710 1/20 0.36
PREP P48147 1/20 0.36
CTSL P07711 1/20 0.36
ACE P12821 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6211014 0.87 CTSB (0.39) KCNA5LMNASMN1; SMN2TP53GFER
SCHEMBL6209447 0.86 ALDH1A1 (0.41) KCNA5LMNASMN1; SMN2TP53GFER
SCHEMBL6209727 0.85 CHRM4 (0.42) LMNASMN1; SMN2TP53GAACTSK
SCHEMBL6210874 0.84 ALDH1A1 (0.40) LMNASMN1; SMN2GAACTSKALDH1A1
SCHEMBL6211270 0.84 TGM2 (0.41) KCNA5GAACTSKCTSSKEAP1
SCHEMBL6210327 0.84 GAA (0.45) LMNATP53GAA
SCHEMBL6209043 0.84 LMNA (0.41) LMNASMN1; SMN2CTSKALDH1A1
SCHEMBL6212088 0.82 SLC6A5 (0.40) LMNACTSKALDH1A1MAPT
SCHEMBL6210258 0.82 POLB (0.42) LMNASMN1; SMN2GAACTSKMAPT
SCHEMBL4048929 0.82 CTSK (0.52) CTSKCTSBCTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed